ATP synthase is a promising target for identifying activated and non-activated adipose tissues

C Caitlin V.M.L. Jie A Aro Delparente T Tongtong Wang (School of Chemical Science and Engineering, Tongji University, 1239 Siping Rd, Shanghai, 200092, China) L Lisa Reichert P Petra Krajnovic M Marc Schläppi L Lukas Reininger L Laura T. L. Brandt C Claudia Keller J Julien Orts (Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 2F 353, Vienna, A-1090, Austria) R Roland Riek (Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland) S Stefanie D. Krämer M Markus Stoffel C Christian Wolfrum R Roger Schibli L Linjing Mu (ETH Zürich, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 4, 8093 Zürich, Switzerland)

Abstract

Abstract Adipose tissue has gained increasing attention as a therapeutic target to combat human obesity and related metabolic disorders. We propose ATP synthase as a target to identify activated and non-activated adipose tissue. We investigated ATP synthase using the radiotracer [ 11 C]J147 and confirmed the specificity of the radiotracer by in vitro autoradiography, cell knockdown studies, and in vivo competition binding studies. In addition to the interscapular brown adipose tissue (BAT), [ 11 C]J147 could visualise several other BAT depots (supraspinal, infrascapular and axillary BAT) via in vivo positron emission tomography imaging after activation with a β 3 -adrenergic receptor agonist, as confirmed by immunohistochemistry and biodistribution studies. Furthermore, [ 11 C]J147 demonstrated higher sensitivity for BAT and WAT (white adipose tissue) identification compared to the commonly used radiotracer [ 18 F]FDG and the mitochondrial complex I tracer [ 18 F]BCPP-EF. Our study uncovers ATP synthase as a promising target for monitoring adipose tissue and [ 11 C]J147 could facilitate drug development for metabolic diseases such as obesity.

Article Details

Volume / Issue Vol. 17, Issue 1
Published April 15, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (16)

C

Caitlin V.M.L. Jie

A

Aro Delparente

T

Tongtong Wang

School of Chemical Science and Engineering, Tongji University, 1239 Siping Rd, Shanghai, 200092, China

L

Lisa Reichert

P

Petra Krajnovic

M

Marc Schläppi

L

Lukas Reininger

L

Laura T. L. Brandt

C

Claudia Keller

J

Julien Orts

Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 2F 353, Vienna, A-1090, Austria

R

Roland Riek

Institute for Molecular Physical Science, Vladimir Prelog Weg 2, Zürich, 8093, Switzerland

S

Stefanie D. Krämer

M

Markus Stoffel

C

Christian Wolfrum

R

Roger Schibli

L

Linjing Mu

ETH Zürich, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 4, 8093 Zürich, Switzerland